ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 57 filers reported holding ALPINE IMMUNE SCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $34,186,918 | +11.4% | 2,985,757 | 0.0% | 2.27% | +23.9% |
Q2 2023 | $30,693,582 | +33.2% | 2,985,757 | 0.0% | 1.83% | +9.8% |
Q1 2023 | $23,050,044 | +5.0% | 2,985,757 | 0.0% | 1.67% | +22.4% |
Q4 2022 | $21,945,314 | +2.1% | 2,985,757 | 0.0% | 1.36% | -17.6% |
Q3 2022 | $21,497,000 | -15.4% | 2,985,757 | 0.0% | 1.66% | -31.0% |
Q2 2022 | $25,409,000 | -32.3% | 2,985,757 | -28.7% | 2.40% | -25.1% |
Q1 2022 | $37,546,000 | – | 4,185,757 | – | 3.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 2,571,450 | $32,400,000 | 2.50% |
Omega Fund Management, LLC | 1,284,900 | $16,190,000 | 2.43% |
Avidity Partners Management LP | 1,248,000 | $15,725,000 | 0.51% |
Samsara BioCapital, LLC | 399,190 | $5,030,000 | 0.51% |
EcoR1 Capital, LLC | 741,290 | $9,340,000 | 0.50% |
DAFNA Capital Management LLC | 113,202 | $1,426,000 | 0.42% |
TIGER MANAGEMENT L.L.C. | 137,728 | $1,735,000 | 0.39% |
Orbimed Advisors | 3,070,955 | $38,694,000 | 0.34% |
SPHERA FUNDS MANAGEMENT LTD. | 198,260 | $2,498,000 | 0.22% |
Artal Group S.A. | 593,030 | $7,472,000 | 0.16% |